Chinese Journal of New Drugs 2016,25(9)
1029
ÖйúÐÂÒ©ÔÓÖ¾2016ÄêµÚ25¾íµÚ9ÆÚ
£Û×÷Õß¼ò½é£Ý˾Ìì÷£¬Ů£¬½ÌÊÚ£¬Ö÷Òª´Óʾ«ÉñÒ©ÀíѧÑо¿。ÁªÏµµç»°:
(010)82801948£¬E-mail:si． tian-mei@ 163． com。
·ÁÙ´²Ñо¿·
ÅÁÀûßßͪ»ºÊÍƬÁÙ´²ÓÃÒ©Ö¸µ¼Òâ¼û(µÚ ¶þ°æ)
˾Ìì÷
1
£¬»Æ¼ÌÖÒ
2
£¬ÀîÏþ°×
3
£¬½¿ª´ï
2
£¬ÑµÂ
4
£¬ºÂ ΰ
5
£¬Íõ¸ß»ª
6
£¬÷ÆäÒ»
7
£¬ÁõÌú°ñ
8
£¬Àî ÌÎ
9
£¬ÍõѧÒå
10
£¬
Ðí
Ðã·å
11
£¬̷ÇìÈÙ
12
£¬ʩ½£·É
13
£¬½¹Ö¾°²
14
£¬Àî Òã
15
£¬ÓÚ ÐÀ
1
(1±±¾©´óѧµÚÁùÒ½Ôº(¾«ÉñÎÀÉúÑо¿Ëù) £¬±±
¾©100083;2ÉϺ£Êо«ÉñÎÀÉúÖÐÐÄ£¬ÉϺ£200030;3ÖйúÒ½¿Æ´ó
ѧµÚÒ»¸½ÊôÒ½Ôº£¬ÉòÑô110001;4±±¾©»ØÁú¹ÛÒ½Ôº£¬±±¾©100096;5ÖÐÄÏÏæÑÅ´óѧ¸½ÊôµÚ¶þÒ½Ôº£¬³¤É³410011;
6Î人´óѧÈËÃñÒ½Ôº£¬Î人430060;7ËÕÖݹã¼ÃÒ½Ôº£¬ËÕÖÝ215008;8ÉîÛÚ¿µÄþÒ½Ôº£¬ÉîÛÚ518003;
9ËÄ´¨´óѧ»ªÎ÷Ò½Ôº£¬³É¶¼610041;10ºÓ±±Ò½¿Æ´óѧµÚÒ»Ò½Ôº£¬Ê¯¼Òׯ050030;11À¥Ã÷ҽѧԺµÚÒ»¸½ÊôÒ½
Ժ£¬À¥Ã÷650032;12µÚËľüÒ½´óѧµÚÒ»¸½ÊôÒ½ÔºÎ÷¾©Ò½Ôº£¬Î÷°²710032;13Õã½´óѧҽѧԺ¾«ÉñÎÀÉúÖÐÐÄ£¬
º¼ÖÝÊеÚÆßÈËÃñÒ½Ôº£¬º¼ÖÝ310013;14ɽ¶«Ê¡Á¢Ò½Ôº£¬¼ÃÄÏ250021;15Î人Êо«ÉñÎÀÉúÖÐÐÄ£¬Î人430022)
£ÛժҪ£ÝÅÁÀûßßͪ»ºÊÍƬ(paliperidone extended release£¬ÅÁÀûßßͪEＲ)ÊÇ2009ÄêÔÚÖйúÉÏÊеÄÒ»ÖÖÐÂ
ÐÍ¿¹¾«Éñ²¡Ò©Îï。2011Äê·¢±íµÄ《ÅÁÀûßßͪ»ºÊÍƬÁÙ´²ÓÃÒ©Ö¸µ¼Òâ¼û 》°ïÖúÁËÒ½ÉúÔÚÁÙ´²Êµ¼ùÖкÏÀíʹÓÃ
ÅÁÀûßßͪEＲ。½üÄêÀ´£¬Ëæ×ÅÅÁÀûßßͪEＲÔÚÁÙ´²Êµ¼ùÖеĹ㷺ӦÓúÍϵͳÑо¿£¬»ýÀÛÁËÔ½À´Ô½¶àµÄÑо¿Êý
¾ÝºÍʵ¼ù¾Ñ飬ÌرðÊÇ»ùÓÚÎÒ¹úÈËȺµÄÑо¿Êý¾Ý£¬ÎªÆäÔÚÎÒ¹ú¼°È«ÇòµÄ¹æ·¶Ê¹ÓÃÌṩÁËÖØÒªËزÄ。ΪÁ˽øÒ»
²½ÓÅ»¯ÅÁÀûßßͪEＲµÄÁÙ´²Ó¦Ó㬸ÄÉÆ»¼ÕßµÄÖÎÁƽá¾Ö£¬ÔÚ×ÛºÏ×îÐÂÑо¿Ö¤¾ÝºÍÁÙ´²Êµ¼ù¾ÑéµÄ»ù´¡ÉÏ£¬±¾
ÎĶÔ《ÅÁÀûßßͪ»ºÊÍƬÁÙ´²ÓÃÒ©Ö¸µ¼Òâ¼û》½øÐиüкÍÍêÉÆ。
£Û¹Ø¼ü´Ê£Ý¾«Éñ·ÖÁÑÖ¢;ÅÁÀûßßͪ»ºÊÍƬ;ÁÙ´²ÓÃÒ©;ºÏÀíÓÃÒ©
£ÛÖÐͼ·ÖÀàºÅ£ÝＲ971． 41£ÛÎÄÏ×±êÖ¾Âë£ÝA £ÛÎÄÕ±àºÅ£Ý1003 － 3734(2016)09 － 1029 － 07
Clinical recommendation on paliperidone extended-release
tablets(second edition)
SI Tian-mei
1
£¬HUANG Ji-zhong
2
£¬LI Xiao-bai
3
£¬JIANG Kai-da
2
£¬YANG Fu-de
4
£¬HAO Wei
5
£¬
WANG Gao-hua
6
£¬MEI Qi-yi
7
£¬LIU Tie-bang
8
£¬LI Tao
9
£¬WANG Xue-yi
10
£¬XU Xiu-feng
11
£¬
TAN Qing-rong
12
£¬SHI Jian-fei
13
£¬JIAO Zhi-an
14
£¬LI Yi
15
£¬YU Xin
1
(1Peking University the Si
【精神科】帕利哌酮缓释片临床用药指导意见（第二版）.pdf